Founding Cohort 2026, 9 spots remaining · 50% off Founders Rate For Life →
Authoritize.ai

Industries

Marketing for TRT and hormone clinics, inside the label

Testosterone is a controlled substance with a narrow approved use, and the FDA and FTC both read clinic marketing. Authoritize builds owned, physician-signed content that brings in qualified candidates without the optimization and anti-aging claims that draw letters.

Why hormone marketing carries real risk

Testosterone is a Schedule III controlled substance, and its approved indication is classical hypogonadism tied to a medical condition, not aging. The trouble usually starts when the marketing treats Low T as a universal mid-life diagnosis, or promises energy, libido, muscle, weight loss, or feeling decades younger. Those are outcome claims the FTC expects you to substantiate, and the evidence often will not carry them. Add direct-to-consumer telehealth prescribing at scale and the exposure compounds. Our hormone enforcement guide walks the concrete patterns, and the Atlas catalogs the real actions.

Compliant hormone copy still converts

The fix is not to say less, it is to say it accurately. Describe the symptoms and candidacy honestly, stay inside the approved indication, drop the guaranteed outcomes and the reverse-aging language, disclose the real risks, and let a licensed physician stand behind the clinical statements. The patient searching whether they actually need testosterone is looking for a straight answer, and the straight answer ranks, earns trust, and stays defensible at the same time.

What Authoritize builds for hormone clinics

Owned articles and authority pages that answer what prospective patients actually search about symptoms, candidacy, and what therapy involves, screened against FDA and FTC guidelines inside the pipeline, and signed by your supervising physician as the reviewer of record. It is the same content engine described on our compliant content page, tuned to hormones. You can pressure-test any existing page right now in the free Claim Checker.

Frequently asked questions

What is the best way to market a TRT or hormone clinic without drawing an FDA or FTC letter?

Testosterone is a controlled substance with a narrow approved use, so the marketing has to stay close to the label. The clinics that do this well treat compliance as part of the content, not a disclaimer underneath it. Authoritize builds owned, physician-signed articles for hormone clinics, screened against the same FDA and FTC patterns that produce real enforcement, and built to rank on Google and get cited by AI search. The free Claim Checker runs that screen on copy you already have.

What gets a hormone clinic an FDA or FTC letter?

Usually reaching past the approved indication. Testosterone is approved for classical hypogonadism tied to a medical condition, not for age. Marketing that frames Low T as a universal mid-life diagnosis, or promises energy, libido, muscle, weight loss, or feeling decades younger, moves into claims the FTC expects you to substantiate and often cannot. Running that at telehealth scale only raises the exposure.

Can you market testosterone therapy compliantly at all?

Yes. The goal is not to say less, it is to say it accurately. Describe the symptoms and candidacy honestly, stay inside the approved indication, drop the guaranteed outcomes and anti-aging language, disclose the real risks, and let a licensed physician stand behind every clinical statement. The patient searching whether they actually need testosterone wants a straight answer, and the straight answer is also the compliant one.

Does Authoritize replace our physician’s review?

No. Authoritize screens content against documented enforcement patterns and drafts it to be defensible, but your supervising physician is the reviewer of record and the final gate on every clinical claim. The screen informs that review, it never substitutes for it.